CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

First patient in Skylark Bio’s Phase I/II trial receives SKY-GJB2 gene therapy

Phase 1
Related Companies

Read the original article

Published by Clinical Trials Arena on August 12, 2026 8:21 AM

Read Original